Polar Capital’s iShares Biotechnology ETF IBB Stock Holding History

Polar Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-16,044	Closed	-$1.37M	–	275
2014 Q2	$1.37M	Sell	16,044 -43,956	-73%	-$3.46M	0.03%	234
2014 Q1	$4.73M	Sell	60,000 -63,450	-51%	-$5.29M	0.11%	190
2013 Q4	$9.33M	Sell	123,450 -7,200	-6%	-$511K	0.22%	156
2013 Q3	$9.13M	Buy	+130,650	New	+$8.56M	0.24%	152

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Polar Capital's IBB Position: Q3 2014 in Review

Polar Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2014, closing a stake of 16,044 shares — an estimated $1.37M sold.

Polar Capital first reported a position in IBB in Q3 2013 and held it in 4 quarters. The position peaked at $9.33M in Q4 2013. 318 funds tracked by Wall St. Rank hold IBB as of Q3 2014.

Polar Capital reported no remaining iShares Biotechnology ETF position as of Q3 2014 after selling out during the quarter.
Polar Capital sold 16,044 iShares Biotechnology ETF shares in Q3 2014, an estimated $1.37M.
Polar Capital first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 4 quarters.
Polar Capital's iShares Biotechnology ETF position peaked at $9.33M in Q4 2013.
318 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2014.

Based on Polar Capital's 13F filing for Q3 2014, filed 13 Nov 2014.